NCT03767582 2025-12-03
Trial of Neoadjuvant and Adjuvant Nivolumab and BMS-813160 With or Without GVAX for Locally Advanced Pancreatic Ductal Adenocarcinomas.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1/2 Completed
Clinical Trials
26 trialsNCT04021043 2025-12-03
BMS-986156, Ipilimumab, and Nivolumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Lung/Chest or Liver Cancers
M.D. Anderson Cancer Center
Phase 1/2 Completed
NCT00492817 2025-10-24
Evaluation of Single Session Stereotactic Body Radiotherapy
M.D. Anderson Cancer Center
Phase 1/2 Completed
NCT03383302 2025-08-01
STILE
Royal Marsden NHS Foundation Trust
Phase 1/2 Completed
NCT04098432 2024-09-23
CA209-9KH
University Hospital Hradec Kralove
Phase 1/2 Completed
NCT02052648 2024-03-27
Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain Tumors
Lumos Pharma
Phase 1/2 Completed
NCT02581787 2024-03-27
SABR-ATAC: A Trial of TGF-beta Inhibition and Stereotactic Ablative Radiotherapy for Early Stage Non-small Cell Lung Cancer
Stanford University
Phase 1/2 Completed
NCT03749460 2023-12-29
Nivolumab and Ipilimumab and Stereotactic Body Radiation Therapy in Treating Patients With Salivary Gland Cancers
University of Washington
Phase 1/2 Completed
NCT03340974 2023-12-15
Pilot Dose Escalation Trial of Stereotactic Body Radiation Therapy (SBRT) in Combination With GC4419 in Pancreatic Cancer
Galera Therapeutics, Inc.
Phase 1/2 Completed
NCT02407171 2023-10-31
Evaluating the Combination of MK-3475 and Sterotactic Body Radiotherapy in Patients With Metastatic Melanoma or NSCLC
Yale University
Phase 1/2 Completed
NCT03399552 2023-10-23
Stereotactic Body Radiation Therapy and Avelumab Immunotherapy for Treatment of Malignant Mesothelioma
Memorial Sloan Kettering Cancer Center
Phase 1/2 Completed
NCT00547339 2022-12-07
Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer
University of Texas Southwestern Medical Center
Phase 1/2 Completed
NCT00750269 2022-06-09
Stereotactic Body Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer
Radiation Therapy Oncology Group
Phase 1/2 Completed
NCT01497808 2021-08-10
RADVAX™: A STRATIFIED PHASE I/II DOSE ESCALATION TRIAL OF HYPOFRACTIONATED RADIOTHERAPY FOLLOWED BY IPILIMUMAB IN METASTATIC MELANOMA
Abramson Cancer Center at Penn Medicine
Phase 1/2 Completed
NCT01120639 2021-08-06
Tx-Treatment
Stanford University
Phase 1/2 Completed
NCT00152906 2020-08-14
Stereotactic Radiotherapy (SRT) Liver (COLD 1)
University Health Network, Toronto
Phase 1/2 Completed
NCT00591838 2019-07-30
SBRT
Washington University School of Medicine
Phase 1/2 Completed
NCT01543672 2019-06-27
VOLUMES
The Netherlands Cancer Institute
Phase 1/2 Completed
NCT00777894 2019-05-15
Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
Swiss Cancer Institute
Phase 1/2 Completed
NCT00311597 2017-03-14
Extracranial Stereotactic Radiosurgery in Treating Patients With Solid Tumors
Wake Forest University Health Sciences
Phase 1/2 Completed
NCT02334709 2017-01-11
Phase I/II Trial of Stereotactic Body Radiotherapy With Concurrent Fixed Dose Tyrosine Kinase Inhibitors in Metastatic Renal Cell Carcinoma: Dose Limiting Toxicity and Abscopal Effect.
University Hospital, Ghent
Phase 1/2 Completed
NCT01304160 2016-08-05
Role of Cyberknife Stereotactic Radiation Therapy (SBRT) Followed by Gemcitabine for Patients With Locally Advanced Pancreatic Cancer
Centre hospitalier de l'Université de Montréal (CHUM)
Phase 1/2 Completed
NCT00888823 2016-03-16
Phase I/II Study of Fractionated Stereotactic Radiotherapy for Early Stage Non-Small Cell Lung Cancer
AHS Cancer Control Alberta
Phase 1/2 Completed
NCT00238602 2012-07-13
Evaluation of Cyberknife Precision Radiation Delivery System for Unresectable Malignant Lung Cancer
Stanford University
Phase 1/2 Completed
NCT00185666 2010-07-14
Cyberknife Precision Radiation Delivery System for Tumors of the Spine
Stanford University
Phase 1/2 Completed
NCT00178243 2006-09-08
Feasibility of Treatment of Cancer Involving the Liver With High Dose Radiation
University of Rochester
Phase 1/2 Completed